[Pharmacotherapy of chronic obstructive pulmonary disease in patients with indications for long-term home oxygen therapy].
The authors submit a cross-sectional analysis of out-patient pharmacotherapy of chronic obstructive lung disease in 138 patients where long-term home oxygen therapy was indicated. To this group of patients no inhalatory bronchodilatating drugs were administered in 19.6% of the patients! The authors provide evidence of a non-significant better survival of patients who used inhalatory bronchodilatating drugs. From the mentioned group during the follow up period 41 (29.7%) died with a mean survival of 16.5 +/- 11.9 (0-39) months. Based on the mentioned results the authors draw attention to the relatively late indication of long-term home oxygen therapy and also to the fact that pharmacotherapy of patients with chronic obstructive lung disease indicated for long-term home oxygen therapy is not fully exploited and its optimalization could lead to better patient survival.